Marketing will be the main focus of any changes made to companies’ commercial approaches
The US Food and Drug Administration has approved AstraZeneca’s revised marketing application for blood-thinning drug Brilinta
Roche has completed the full acquisition of Germany-based mtm laboratories, a company specialising in products for cervical cancer diagnosis
Doctors.net.uk has launched a mobile phone app providing members with details of the latest medical conferences via their smartphone
Teva Pharmaceutical has completed the full acquisition of Japanese generics manufacturer Taiyo in a cash deal worth $934m
Contract research organisation inVentiv Health has completed the acquisition of PharmaNet Development Group, a global drug development service provider to the pharma sector
The US Food and Drug Administration has told Transcept Pharmaceuticals its insomnia drug, Intermezzo, is not ready for marketing approval
Lilly UK has launched Bydureon, the first once-weekly glucagon-like peptide (GLP-1) receptor agonist, for the treatment of type 2 diabetes
Effective use of digital communication will help agencies best represent their clients in times of reform
